Tomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter @TomiKilgore.
Shares of Johnson & Johnson JNJ, +0.43% rallied 0.8% in premarket trading Tuesday, after the drug maker and medical technology company reported third-quarter profit and sales that rose above expectations, amid strength in its MedTech business. Net earnings from continuing operations were $4.31 billion, or $1.69 a share, after $4.31 billion, or $1.62 a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share increased 19.3% to $2.
Sales grew 6.8% to $21.35 billion, above the FactSet consensus of $21.04 billion, as Innovative Medicine sales rose 5.1% to $13.89 billion and MedTech sales jumped 10.0% to $7.46 billion. For 2023, the company raised its guidance ranges for adjusted EPS to $10.07 to $10.13 from $10.00 to $10.10 and for sales to $83.6 billion to $84.0 billion from $83.2 billion to $84.0 billion. The stock has slipped 1.0% over the past three months through Monday while the Dow Jones Industrial Average DJIA, +0.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
BioNTech’s stock sinks after disclosing expected charge of up to nearly $1 billion resulting from Pfizer’s write offs of COVID productsTomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter TomiKilgore.
Weiterlesen »
Novo Nordisk to buy hypertension treatment from for $1.3 billion from KBP BiosciencesTomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter TomiKilgore.
Weiterlesen »
McKesson doesn’t expect Rite Aid’s bankruptcy to have much affect on profit outlook, liquidityTomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter TomiKilgore.
Weiterlesen »
Bitcoin’s surge gives a boost to crypto-related stocksTomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter TomiKilgore.
Weiterlesen »
Charles Schwab stock drops after revenue falls a bit shy of expectations, amid trading weaknessTomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter TomiKilgore.
Weiterlesen »
India-based HDFC Bank reports 33% jump in revenue, re-appoints CEO for 3 yearsTomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter TomiKilgore.
Weiterlesen »